Sponsor Dossier
Norgine
Sponsor Dossier for Norgine. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ANGUSTA
- Brand: FERACCRU
- Brand: IFINWIL
- Brand: MOVICOL
- Brand: MOVIPREP
- Brand: PEDMARQSI
- Brand: PLENVU
- Brand: XIFAXAN
About
Norgine is an Australian Private Company with ABN 78005022882, registered in NSW. The entity is active and registered for GST from 2000-07-01.
Portfolio
Norgine's ARTG portfolio comprises 8 total brands, of which 7 are indexable. Seven brands have Product Information on file, 2 brands are PBS-listed, and 3 brands have PBAC outcomes on record. Notable brands include ANGUSTA, FERACCRU, IFINWIL, MOVICOL, MOVIPREP, PEDMARQSI, PLENVU, and XIFAXAN.
Therapeutic focus
— Gastroenterology: 3 brands — Oncology: 2 brands — Infectious Disease: 1 brand — Women's Health: 1 brand — Haematology: 1 brand
PBS footprint
Two brands in Norgine's portfolio are PBS-listed, with the most recent schedule update on 2026-05-01.
Regulatory activity
Norgine's most recent PBAC outcome is dated 2025-03-01, with 3 brands holding PBAC outcomes on record.